title: Effects of haloperidol on CSF glutamate levels in drug-naive schizophrenic patients.
authors.forename: R
authors.initials: R
authors.lastname: Labarca
authors.forename: H
authors.initials: H
authors.lastname: Silva
authors.forename: S
authors.initials: S
authors.lastname: Jerez
authors.forename: A
authors.initials: A
authors.lastname: Ruiz
authors.forename: P
authors.initials: P
authors.lastname: Renterías
authors.forename: C
authors.initials: C
authors.lastname: Ogalde
authors.forename: G
authors.initials: G
authors.lastname: Bustos
mesh_terms: D000293:Adolescent; D000328:Adult; D018492:Dopamine Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D018698:Glutamic Acid / Q000134:cerebrospinal fluid*; D006220:Haloperidol / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D012559:Schizophrenia / Q000134:cerebrospinal fluid / Q000188:drug therapy*
chemical_list: D018492:Dopamine Antagonists; D018698:Glutamic Acid; D006220:Haloperidol